Antibiotics | No. (%) MSSA (n = 68) | No. (%) MRSA (n = 54) | Overall resistance No. (%) | p value | ||||
---|---|---|---|---|---|---|---|---|
Susceptible | Intermediate | Resistant | Susceptible | Intermediate | Resistant | |||
Clindamycin | 56 (82.4) | 0 (0) | 11 (16.2)a | 27 (50) | 0 (0) | 4 (7.4)b | 15(12.4%) | 0.000d |
Erythromycin | 56 (82.4) | 0 (0) | 12 (17.6) | 25 (46.3) | 0 (0) | 29 (53.7) | 41(33.6) | 0.000d |
Gentamicin | 57 (83.8) | 1 (1.5) | 10 (14.7) | 45 (83.3) | 3 (50) | 6 (11.1) | 16 (13.1) | 0.401 |
Linezolid | 68 (100) | 0 (0) | 0 (0) | 54 (100) | 0 (0) | 0 (0) | 0 (0) | – |
Oxacillin | 68 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 54 (100) | 54 (44.3) | 0.000d |
Penicillin | 22 (32.4) | 0 (0) | 46 (67.6) | 0 (0) | 0 (0) | 54 (100) | 100 (82.0) | 0.000d |
Rifampicin | 68 (100) | 0 (0) | 0 (0) | 53 (98.1) | 0 (0) | 1 (1.9) | 1 (0.8) | 0.260 |
Cotrimoxazole | 56 (82.4) | 0 (0) | 12 (17.6) | 49 (90.7) | 0 (0) | 5 (9.3) | 17 (13.9) | 0.184 |
Tetracycline | 57 (83.8) | 0 (0) | 11 (16.2) | 46 (85.2) | 0 (0) | 8 (14.8) | 19 (15.6) | 0.837 |
Vancomycin | 68(100) | 0 (0) | 0 (0) | 54 (100) | 0 (0) | 0 (0) | 0 (0) | – |
Ciprofloxacin | 66 (97.1) | 0 (0) | 2 (2.9) | 9 (16.7) | 0 (0) | 45 (83.3) | 47 (38.5) | 0.000d |
Levofloxacin | 67 (98.5) | 0 (0) | 1 (1.5) | 9 (16.7) | 0 (0) | 45 (83.3) | 46 (37.7) | 0.000d |
Moxifloxacinc | 57 (98.3) | 1 (1.7) | 0 (0) | 9 (16.7) | 4 (7.4) | 41(75.9) | 41 (36.6) | 0.000d |
Cefoxitin | 68 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 54 (100) | 54 (44.3) | 0.000d |